Abstract

AimsTreating to low disease activity is routine in rheumatoid arthritis, but no comparable goal has been defined for systemic lupus erythematosus (SLE). We sought to define and validate a Lupus...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
437. Association of Neostigmine, Clonidine and Ropivacaine 0,75% I.T for Orthopaedic Treatment of Proximal Femoral Fracture in Elderly
C Privitera ... G Guzzetta
Regional Anesthesia & Pain Medicine | VOL. 33
C Privitera, et. al.C Privitera ... G Guzzetta
01 Sep 2008
FRI0259 Lupus low disease activity state (LLDAS) in patients with lupus nephritis (LN)
Dv Monova ... M Ivanova
Annals of the Rheumatic Diseases | VOL. 76
Dv Monova, et. al.Dv Monova ... M Ivanova
01 Jun 2017
06 LLDAS is an excellent outcome measure, but does it really capture patients with true LDA?
Andrea Doria
Lupus Science & Medicine | VOL. 9
Andrea DoriaAndrea Doria
01 Apr 2022
Transient unilateral mydriasis as the presenting sign of aortic and carotid dissection.
R Inzelberg ... G.M Groisman
Neurology | VOL. 55
R Inzelberg, et. al.R Inzelberg ... G.M Groisman
26 Dec 2000
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers